Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

Humoral and cellular immunity rates in chemical plant workers producing dust pesticides

Piotr Kłuciński, Stefan Kossmann, Jerzy Tustanowski, Daniela Friedek, Bożena Kamińska-Kołodziej

Med Sci Monit 2001; 7(6): CR1270-1274 :: ID: 508175

Abstract

Background: Exposure to pesticides may affect humoral and cell-mediated immunity. Material and methods: The study group was composed of 24 men employed in the production of dust pesticides and 23 females performing ancillary jobs under conditions of lower pesticide exposure. Chronic bronchitis was diagnosed in 10 males (41.7%) and 13 females (56.5%). The workers were exposed to: triazines, carbamates and dithiocarbamates, carbendazim, captan, dodine, dichlorophenoxy acetic acid (2,4-D), and cupric oxychloride. Silica, kaolin, chalk, and talc were used as carriers. The average workplace air concentrations of pesticides did not exceed the MAC. The serum concentrations of immunoglobulins G, A and M, complement component C3, and circulating immune complexes (CIC) were estimated. The peripheral blood leukocyte count and percentage of CD3, CD4, CD8, CD19 lymphocytes were evaluated.
Results: IgA and CIC concentrations in the female group were higher as compared to controls, whereas the percentage of CD3, CD4, CD8 cells was significantly lower, as opposed to an increased percentage of CD19 cells. The male group showed lower CIC concentrations, and the C3 complement component level was significantly higher. The decreased percentage of CD3 cells was accompanied by a higher CD19 cells ratio. The white blood cell count was higher in the males. No significant changes were found in other immunity parameters.
Conclusion: The results of the study showed changes in some components of humoral and cellular immunity, which may influence damage to the respiratory system.

Keywords: dust pesticides, humoral immunity, cellular immunity

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

26 Feb 2024 : Clinical Research  

Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...

Med Sci Monit In Press; DOI: 10.12659/MSM.942509  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750